Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-squamous Non-small Cell Lung Cancer Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00087412
What this trial is testing

S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungLarge Cell Lung CancerRecurrent Non-small Cell Lung Cancer+3 more
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Study completedNCT01260181
What this trial is testing

Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 30
Testing effectiveness (Phase 2)Ended earlyNCT02087241
What this trial is testing

Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer

Who this might be right for
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer
AstraZeneca 22
Testing effectiveness (Phase 2)WithdrawnNCT05364645
What this trial is testing

Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+2 more
SWOG Cancer Research Network
Testing effectiveness (Phase 2)Study completedNCT01266447
What this trial is testing

Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+5 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Ended earlyNCT01646125
What this trial is testing

An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations

Who this might be right for
Advanced Non Small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Study completedNCT00036920
What this trial is testing

TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00251524
What this trial is testing

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Veeda Oncology 69
Testing effectiveness (Phase 2)Study completedNCT01829113
What this trial is testing

Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer

Who this might be right for
Non Squamous Non Small Cell Lung Cancer
SCRI Development Innovations, LLC 155
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Large-scale testing (Phase 3)Not Yet RecruitingNCT06335355
What this trial is testing

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 401
Testing effectiveness (Phase 2)Study completedNCT03468985
What this trial is testing

Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00828009
What this trial is testing

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 70
Testing effectiveness (Phase 2)Study completedNCT00227019
What this trial is testing

Phase 2 Trial of Bevacizumab in Combination With Pemetrexed

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Lung CancerNeoplasm Metastasis
Heather Wakelee 16
Testing effectiveness (Phase 2)Study completedNCT00040794
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+4 more
National Cancer Institute (NCI) 144
Testing effectiveness (Phase 2)Study completedNCT00960999
What this trial is testing

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 94
Testing effectiveness (Phase 2)Ended earlyNCT00509366
What this trial is testing

Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Duke University 101
Testing effectiveness (Phase 2)Ended earlyNCT00958321
What this trial is testing

Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

Who this might be right for
Lung CancerMetastatic Cancer
Cancer Trials Ireland 40
Not applicableStudy completedNCT00004138
What this trial is testing

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 303
Testing effectiveness (Phase 2)Study completedNCT05077709
What this trial is testing

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Who this might be right for
Lung Cancer Non Small CellHead and Neck Squamous Cell CarcinomaUrothelial Carcinoma Bladder
IO Biotech 63
Next Page